Cargando…

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit

A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), caused a worldwide pandemic. Our aim in this study is to produce new fusion inhibitors against SARS-CoV-2, which can be the basis for developing new antiviral drugs. The fusion core comprising the heptad repeat domain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandeel, Mahmoud, Yamamoto, Mizuki, Tani, Hideki, Kobayashi, Ayako, Gohda, Jin, Kawaguchi, Yasushi, Park, Byoung Kwon, Kwon, Hyung-Joo, Inoue, Jun-ichiro, Alkattan, Abdallah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094075/ https://www.ncbi.nlm.nih.gov/pubmed/33424013 http://dx.doi.org/10.4062/biomolther.2020.201

Ejemplares similares

Discovery of New Potent anti-MERS CoV Fusion Inhibitors
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein
por: Yamamoto, Mizuki, et al.
Publicado: (2022)

Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion
por: Yamamoto, Mizuki, et al.
Publicado: (2020)

N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Δ4-Desaturase 1-Independent Mechanism
por: Hayashi, Yasuhiro, et al.
Publicado: (2021)

The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
por: Yamamoto, Mizuki, et al.
Publicado: (2020)

Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2022)

TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-κB activation
por: YAMAMOTO, Mizuki, et al.
Publicado: (2021)

The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells
por: Yoo, Dongwan, et al.
Publicado: (1991)

BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018)

Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19
por: Ogura, Hideki, et al.
Publicado: (2022)

In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases
por: Hassan, Ahmed H. E., et al.
Publicado: (2023)

Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein
por: Spiga, Ottavia, et al.
Publicado: (2003)

Construction of a subunit-fusion nitrile hydratase and discovery of an innovative metal ion transfer pattern
por: Xia, Yuanyuan, et al.
Publicado: (2016)

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein
por: Park, Byoung Kwon, et al.
Publicado: (2021)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins
por: Polo-Megías, Daniel, et al.
Publicado: (2022)

Mutagenic Distinction between the Receptor-Binding and Fusion Subunits of the SARS-CoV-2 Spike Glycoprotein and Its Upshot
por: Penner, Robert Clark
Publicado: (2021)

SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2023)

Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
por: Hu, Xin, et al.
Publicado: (2021)

Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
por: Tanikawa, Takashi, et al.
Publicado: (2022)

Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex
por: Park, Byoung Kwon, et al.
Publicado: (2019)

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
por: Ng, Kim Tien, et al.
Publicado: (2021)

The S2 Subunit of QX-type Infectious Bronchitis Coronavirus Spike Protein Is an Essential Determinant of Neurotropism
por: Cheng, Jinlong, et al.
Publicado: (2019)

Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection
por: Liu, Dehua, et al.
Publicado: (2018)

Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
por: Cory, Theodore J., et al.
Publicado: (2021)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

Inference of nonlinear receptive field subunits with spike-triggered clustering
por: Shah, Nishal P, et al.
Publicado: (2020)

Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy
por: Gono, Takahisa, et al.
Publicado: (2013)

Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex
por: Choi, Jiyeon, et al.
Publicado: (2019)

Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: Implications for the functional roles of S2 subunit
por: Zeng, Fanya, et al.
Publicado: (2006)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2020)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2021)

The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
por: Shah, Priyanka, et al.
Publicado: (2021)

A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
por: Pang, Wei, et al.
Publicado: (2022)

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
por: Ko, Shih-Han, et al.
Publicado: (2022)

Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages
por: Chiok, Kim, et al.
Publicado: (2023)

Posterior atlantoaxial fusion using a C2 transverse foramen-penetrating screw: A technical note
por: Takeshima, Yasuhiro, et al.
Publicado: (2017)

Protection against infectious bronchitis virus by spike ectodomain subunit vaccine
por: Eldemery, Fatma, et al.
Publicado: (2017)

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
por: Zheng, Zhiqiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekj0gaoeea49gujd612n1n4psf